<DOC>
	<DOCNO>NCT01131260</DOCNO>
	<brief_summary>The purpose research test new instrument , call fetal STAN monitor , may use labor monitor electrical activity baby 's heart . This new instrument design help doctor determine well baby labor . It use along exist electronic fetal monitor use measure baby 's heart rate mother 's contraction birth . The specific purpose research study see new instrument ( fetal STAN monitor ) impact newborn health .</brief_summary>
	<brief_title>Fetal ST Segment T Wave Analysis Labor</brief_title>
	<detailed_description>A Randomized Trial Fetal ECG ST Segment T Wave Analysis Adjunct Electronic Fetal Heart Rate Monitoring ( STAN ) : Fetal ECG analysis ST segment ( STAN ) FDA-approved clinically available United States adjunct interpretation electronic fetal heart rate pattern . There number randomize controlled trial well observational study Europe document utility modality term reduce fetal acidosis birth , decrease need operative vaginal delivery . However , despite endorsement , remain concern application technology United States . None randomize trial perform United States patient case-mix obstetrical practice , use fetal scalp pH , differ Europe , may affect impact technology perinatal outcome . Moreover , result European study uniformly positive . This protocol describe randomize controlled trial STAN technology adjunct electronic fetal heart rate monitoring versus fetal heart rate monitoring alone .</detailed_description>
	<criteria>Singleton , cephalic pregnancy Gestational age least 36 week , 1 day Cervical dilation least 2 cm 7 cm Ruptured membrane Multifetal gestation Planned cesarean delivery Need immediate delivery Absent variability sinusoidal pattern time , Category II fetal heart rate pattern absent variability last 20 minute randomization Inability obtain maintain adequate signal within 3 trial electrode placement Occurrence ST event attempt obtain adequate signal Patient push first stage labor Known major fetal anomaly fetal demise Previous uterine surgery Placenta previa admission Maternal fever great equal 38 C 100.4 F Active HSV infection Known HIV hepatitis infection Other maternal fetal contraindication use STAN monitor Enrollment another labor study Participation trial previous pregnancy No certify authorize provider available</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>STAN</keyword>
	<keyword>Fetal monitoring</keyword>
	<keyword>Fetal acidosis</keyword>
	<keyword>Fetal heart rate monitoring</keyword>
	<keyword>Perinatology</keyword>
</DOC>